Practice guideline for the treatment of patients with major depressive disorder (revision)

American Journal of Psychiatry

Volumn 157, Issue 4 SUPPL., 2000, Pages 1-45

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; AMOXAPINE; ANTIDEPRESSANT AGENT; CITALOPRAM; CLOMIPRAMINE; DESIPRAMINE; DOXEPIN; FLUOXETINE; FLUVOXAMINE; IMIPRAMINE; MAPROTILINE; MIRTAZAPINE; MOCLOBEMIDE; MONOAMINE OXIDASE INHIBITOR; NEFAZODONE; NORTRIPTYLINE; PAROXETINE; PHENELZINE; PROTRIPTYLINE; REBOXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRANYLCYPROMINE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; TRIMIPRAMINE; VENLAFAXINE;

ADVERSE DRUG REACTION; BEHAVIOR THERAPY; COGNITIVE THERAPY; COMORBIDITY; DEPRESSION; ELECTROCONVULSIVE THERAPY; GROUP THERAPY; HUMAN; HYPERICUM PERFORATUM; MAINTENANCE THERAPY; PHOTOTHERAPY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; PSYCHOTHERAPY; REVIEW; TREATMENT PLANNING;

ANTIDEPRESSIVE AGENTS; COMBINED MODALITY THERAPY; DECISION TREES; DEPRESSIVE DISORDER; DRUG ADMINISTRATION SCHEDULE; ELECTROCONVULSIVE THERAPY; HUMANS; PATIENT COMPLIANCE; PHOTOTHERAPY; PSYCHOTHERAPY; RECURRENCE; TREATMENT OUTCOME;

EID: 0034030898     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Agency for Healthcare Policy Research: Evidence Report on Treatment of Depression - Newer Pharmacotherapies. San Antonio Evidence-Based Practice Center. Washington, DC, AH-CPR, Evidence-Based Practice Centers, 1999 [F]
2. American Psychiatric Association: Practice Guideline for the Treatment of Patients With Bipolar Disorder. Am J Psychiatry 1994;151(Dec suppl) [G]
3. American Psychiatric Association: Practice Guideline for Psychiatric Evaluation of Adults. Am J Psychiatry 1995; 152(Nov suppl):63-80 [G]
4. Lin EHB, von Korff M, Katon W, Bush T, Simon GE, Walker E, Robinson P: The role of the primary care physician in patients' adherence to antidepressant therapy. Med Care 1995; 33:67-74 [B]
5. Thase ME, Rush AJ: Treatment-resistant depression, in Psychopharmacology: The Fourth Generation of Progress. Edited by Bloom F, Kupfer DJ. New York, Raven Press, 1995, pp 1081-1097 [F]
6. Frank E, Kupfer DJ: Axis II personality disorders and personality features in treatment-resistant and refractory depression, in Treatment Strategies for Refractory Depression. Edited by Roose SP, Classman AH. Washington, DC, American Psychiatric Press, 1990, pp 207-221 [F]
7. Goldman W, McCulloch J, Cuffel B, Zarin DA, Suarez A, Burns BJ: Outpatient utilization patterns of integrated and split psychotherapy and pharmacotherapy for depression. Psychiatr Serv 1998; 49:477-482 [G]
8. Gray SH: Developing practice guidelines for psychoanalysis. J Psychother Pract Res 1996; 5:213-227 [F]
9. Coyne JC: Strategic therapy, in Affective Disorders and the Family: Assessment and Treatment. Edited by Clarkin JF, Haas GL, Glick JD. New York, Guilford, 1988, pp 89-113 [F]
10. Lejoyeux M, Ades J: Antidepressant discontinuation: a review of the literature. J Clin Psychiatry 1997; 58(suppl 7):11-16 [F]
11. Coupland NJ, Bell CJ, Potokar JP: Serotonin reuptake inhibitor withdrawal. J Clin Psychopharmacol 1996; 16:356-362 [D]
12. Glassman AH, Roose SP: Delusional depression. Arch Gen Psychiatry 1981; 38:424-427 [E]
13. Spiker DG, Weiss JC, Dealy RS, Griffin SJ, Hanin I, Neil JF, Perel JM, Rossi AJ, Soloff PH: The pharmacological treatment of delusional depression. Am J Psychiatry 1985; 142:430-436 [A]
14. Price LH, Conwell Y, Nelson JC: Lithium augmentation of combined neuroleptic-tricyclic treatment in delusional depression. Am J Psychiatry 1983; 140:318-322 [E]
15. Kantor SJ, Glassman AH: Delusional depression: natural history and response to treatment. Er J Psychiatry 1977; 131:351-360 [E]
16. Fink M, Taylor MA: Catatonia: a separate category for DSM-IV? Integrative Psychiatry 1991; 7:2-10 [G]
17. Liebowitz MR, Quitkin FM, Stewart JW, McGrath PJ, Harrison WM, Markowitz JS, Rabkin JG, Tricamo E, Goetz DM, Klein DF: Antidepressant specificity in atypical depression. Arch Gen Psychiatry 1988; 45:129-137 [A]
18. Davidson JR, Miller R, Turnbull CD, Sullivan JL: Atypical depression. Arch Gen Psychiatry 1982; 39:527-534 [G]
19. Quitkin FM, Harrison W, Stewart JW, McGrath PJ, Tricamo E, Ocepek-Welikson K, Rabkin JG, Wager SG, Nunes E, Klein DF: Response to phenelzine and imipramine in placebo nonresponders with atypical depression: a new application of the crossover design. Arch Gen Psychiatry 1991; 48:319-323 [A]
20. Quitkin FM, Stewart JW, McGrath PJ, Liebowitz MR, Harrison WM, Tricamo E, Klein DF, Rabkin JG, Markowitz JS, Wager SG: Phenelzine versus imipramine in the treatment of probable atypical depression: defining syndrome boundaries of selective MAOI responders. Am J Psychiatry 1988; 145:306-311 [A]
21. Goodnick PJ: Acute and long-term bupropion therapy: response and side effects. Ann Clin Psychiatry 1991; 3:311-313 [C]
22. Goodnick PJ, Extein I: Bupropion and fluoxetine in depressive subtypes. Ann Clin Psychiatry 1989; 1:119-122 [C]
23. Pande AC, Birkett M, Fechner-Bates S, Haskett RF, Greden JF: Fluoxetine versus phenelzine in atypical depression. Biol Psychiatry 1996; 40:1017-1020 [A]
24. Sands BF, Ciraulo DA: Cocaine drug-drug interactions. J Clin Psychopharmacol 1992; 12:49-55 [G]
25. Grunhaus L: Clinical and psychobiological characteristics of simultaneous panic disorder and major depression. Am J Psychiatry 1988; 145:1214-1221 [G]
26. Schatzberg AF, Ballenger JC: Decisions for the clinician in the treatment of panic disorder: when to treat, which treatment to use, and how long to treat. J Clin Psychiatry 1991; 52:26-31 [G]
27. Sheehan DV, Davidson JR, Manschreck T, Van Wyck Fleet J: Lack of efficacy of a new antidepressant (bupropion) in the treatment of panic disorder with phobias. J Clin Psychopharmacol 1983; 3:28-31 [C]
28. Clomipramine Collaborative Study Group: Clomipramine in the treatment of patients with obsessive-compulsive disorder. Arch Gen Psychiatry 1991; 48:730-738 [A]
29. Jenike MA, Buttolph L, Baer L, Ricciardi J, Holland A: Open trial of fluoxetine in obsessive-compulsive disorder. Am J Psychiatry 1989; 146:909-911 [A]
30. Stoudemire A, Hill C, Gulley LR, Morris R: Neuropsychological and biomedical assessment of depression-dementia syndromes. J Neuropsychiatry Clin Neurosci 1989; 1:347-361 [C]
31. Caine ED: Pseudodementia: current concepts and future directions. Arch Gen Psychiatry 1981; 38:1359-1364 [G]
32. Akiskal HS, Rosenthal TL, Haykal RF, Lemmi H, Rosenthal RH: Characterological depressions: clinical and sleep EEG findings separating subaffective dysthymias from character spectrum disorders. Arch Gen Psychiatry 1980; 37:777-783 [B]
33. Howland RH: Pharmacotherapy of dysthymia: a review. J Clin Psychopharmacol 1991; 11:83-92 [G]
34. Keller MD, Hanks DL, Klein DN: Summary of the DSM-IV mood disorders field trial and issue overview. Psychiatr Clin North Am 1996; 19:1-28 [F]
35. Thase ME, Reynolds CF, Frank E, Simons AD: Response to cognitive-behavioral therapy in chronic depression. J Psychotherapy Practice and Research 1994; 3:204-214 [B]
36. Conte HR, Karasu TB: A review of treatment studies of minor depression 1980-1981. Am J Psychother 1992; 46:58-74 [F]
37. Frances AJ: An introduction to dysthymia. Psychiatr Annals 1993; 23:607-608 [F]
38. Keller MD, McCullough JP, Rush AJ, Klein DF, Schatzberg AF, Gelenberg J, Thase ME: Nefazodone HCI, cognitive behavioral analysis system of psychotherapy and combination therapy for the acute treatment of chronic depression, in 1999 Annual Meeting New Research Program and Abstracts. Washington, DC, American Psychiatric Association, 1999, p 178 [A]
39. Kocsis JH, Frances AJ, Voss CB, Mann JJ, Mason BJ, Sweeney J: Imipramine treatment for chronic depression. Arch Gen Psychiatry 1988; 45:253-257 [A]
40. Shea MT, Glass DR, Pilkonis PA, Watkins J, Docherty JP: Frequency and implications of personality disorders in a sample of depressed outpatients. J Personal Disord 1987; 1:27-42 [C]
41. Parsons B, Quitkin FM, McGrath PJ, Stewart JW, Tricamo E, Ocepek-Welikson K, Harrison W, Rabkin JG, Wager SG, Nunes E: Phenelzine, imipramine, and placebo in borderline patients meeting criteria for atypical depression. Psychopharmacol Bull 1989; 25:524-534 [A]
42. Shea MT, Pilkonis PA, Beckham E, Collins JF, Elkin I, Sotsky SM, Docherty JP: Personality disorders and treatment outcome in the NIMH Treatment of Depression Collaborative Research Program. Am J Psychiatry 1990; 147:711-718 [A]
43. Rosenthal NE, Sack DA, Carpenter CJ, Parry BL, Mendelson WB, Wehr TA: Antidepressant effects of light in seasonal affective disorder. Am J Psychiatry 1985; 142:163-170 [C]